Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZATMATM0,00
KBATMATM0,10
PKN76,7376,74-1,36
Msft472,52472,590,36
Nokia4,6374,641-1,26
IBM276,36276,590,05
Mercedes-Benz Group AG52,1552,170,12
PFE24,5724,581,21
11.06.2025 16:10:05
Indexy online
AD Index online
select
AD Index online
 

  • 11.06.2025 16:02:18
Victrex PLC (VCTX.L, London)
Poslední obchod Změna (%) Změna (GBP) Objem obchodů (GBP)
7,98 -1,12 -0,09 94 866
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 11.06.2025
Popis společnosti
Obecné informace
Název společnostiVictrex plc
TickerVCT
Kmenové akcie:Ordinary Shares
RICVCTX.L
ISINGB0009292243
Poslední známé roční výsledky30.09.2024
Poslední známé čtvrtletní výsledky31.03.2025
Počet zaměstnanců k 30.09.2024 1 131
Akcie v oběhu k 30.04.2025 87 052 107
MěnaGBP
Kontaktní informace
UliceVictrex Technology Centre
MěstoTHORNTON CLEVELEYS
PSČFY5 4QD
ZeměUnited Kingdom
Kontatní osobaAndrew Hanson
Funkce kontaktní osobyDirector - Investor Relations, Corporate Communications and ESG
Telefon441 253 897 700
Fax441253897701
Kontatní telefon441 253 898 121

Business Summary: Victrex plc is a United Kingdom-based holding company. The principal activity of the Company is the manufacture and sale of high-performance polymers. The Company develops solutions in polyetheretherketone (PEEK) and polyaryletherketone (PAEK) based polymers and selects semi-finished and finished parts. The Company operates through two segments: Sustainable Solutions and Medical. The Sustainable Solutions segment focuses on its energy and industrial, value-added resellers (VAR), automotive, aerospace and electronics markets. The Medical segment is focused on providing specialist solutions for medical device manufacturers. The Company’s subsidiaries include Victrex Manufacturing Limited, Invibio Limited, Invibio Knees Limited, Invibio Device Component Manufacturing Limited and Juvora Limited.
Financial Summary: BRIEF: For the six months ended 31 March 2025, Victrex plc revenues increased 4% to L148.1M. Net income increased from L2.7M to L15.2M. Revenues reflect Medical segment increase of 14% to L30.2M, Sustainable Solutions segment increase of 2% to L115.7M. Net income benefited from Impairment of Financial Investments decrease from L20.1M (expense) to L0K, Result of associate decrease from L20.1M (expense) to L0K. Dividend per share remained flat at L0.13.
Odvětvová klasifikace
TRBC2009Chemicals - Specialty
TRBC2012Specialty Chemicals (NEC)
RBSS2004Chemicals - Specialty
MGINDUSTRYChemicals - Plastics & Rubber
MGSECTORBasic Materials
NAICSPlastics Material and Resin Manufacturing
NAICSOffices of Other Holding Companies
NAICS2007Plastics Material & Resins Mfg
NAICS2007Offices of Other Holding Companies
NAICS1997Plastics Material and Resin Manufacturing
NAICS1997Offices of Other Holding Companies
SICPlastics Materials And Resins
SICHolding Companies, Nec



  • Poslední aktualizace: 11.06.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Executive DirectorJakob Sigurdsson6101.10.201701.10.2017
Chief Financial Officer, Executive DirectorIan Melling-04.07.202204.07.2022
General Counsel, Company SecretaryJane Brisley-